Farwa Ali, M.B.B.S.

  1. Neurologist

Publicaciones

  1. Carlos AF, Sekiya H, Koga S, Pham NTT, Ali F, Botha H, Clark HM, Coon EA, Lowe V, Ahlskog JE, Trejo-Lopez JA, Dickson DW, Whitwell JL, Josephs KA. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism Relat Disord. 2022 Jun 16; 101:9-14 Epub 2022 June 16
    View PubMed
  2. Gatto RG, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Dickson DW, Josephs KA, Whitwell JL. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant. Neuroimage Clin. 2022 May 11; 35:103030 [Epub ahead of print]
    View PubMed
  3. Grijalva RM, Pham NTT, Huang Q, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Weigand SD, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy. Mov Disord. 2022 Apr; 37 (4):702-712 Epub 2021 Dec 31
    View PubMed
  4. Ali F, Benarroch E. What Is the Brainstem Control of Locomotion? Neurology. 2022 Mar 15; 98 (11):446-451
    View PubMed
  5. Bower SM, Weigand SD, Ali F, Clark HM, Botha H, Stierwalt JA, Whitwell JL, Josephs KA. Depression and Apathy across Different Variants of Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2022 Feb; 9 (2):212-217 Epub 2021 Dec 31
    View PubMed
  6. Carlos AF, Tosakulwong N, Weigand SD, Buciuc M, Ali F, Clark HM, Botha H, Utianski RL, Machulda MM, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL. Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies. Brain Commun. 2022; 4 (3):fcac108 Epub 2022 Apr 28
    View PubMed
  7. Lucien F, Benarroch EE, Mullan A, Ali F, Boeve BF, Mielke MM, Petersen RC, Kim Y, Stang C, Camerucci E, Ross OA, Wszolek ZK, Knopman D, Bower J, Singer W, Savica R. Poly (ADP-Ribose) and alpha-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity. PLoS One. 2022; 17 (4):e0264446 Epub 2022 Apr 08
    View PubMed
  8. Hokelekli FO, Duffy JR, Clark HM, Utianski RL, Botha H, Ali F, Stierwalt JA, Machulda MM, Reichard RR, Dickson DW, Whitwell JL, Josephs KA. Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria. Mov Disord. 2022 Jan; 37 (1):213-218 Epub 2021 Oct 10
    View PubMed
  9. Clark HM, Tosakulwong N, Weigand SD, Ali F, Botha H, Pham NTT, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Ahlskog JE, Josephs KA, Whitwell JL. Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy. Mov Disord. 2021 Nov; 36 (11):2669-2675 Epub 2021 Aug 23
    View PubMed
  10. Ali F, Loushin SR, Botha H, Josephs KA, Whitwell JL, Kaufman K. Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy. J Neurol Sci. 2021 Oct 15; 429:118054 Epub 2021 Aug 25
    View PubMed
  11. Hokelekli FO, Ali F, Carlos AF, Martin PR, Clark HM, Duffy JR, Utianski RL, Botha H, St Louis EK, Whitwell JL, Josephs KA. Sleep disturbances in the speech-language variant of progressive supranuclear palsy. Parkinsonism Relat Disord. 2021 Oct; 91:9-12 Epub 2021 Aug 18
    View PubMed
  12. Whitwell JL, Tosakulwong N, Clark HM, Ali F, Botha H, Weigand SD, Sintini I, Machulda MM, Schwarz CG, Reid RI, Jack CR Jr, Ahlskog JE, Josephs KA. Diffusion tensor imaging analysis in three progressive supranuclear palsy variants. J Neurol. 2021 Sep; 268(9):3409-3420. Epub 2021 Mar 12.
    View PubMed
  13. Clark HM, Utianski RL, Ali F, Botha H, Whitwell JL, Josephs KA. Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. Am J Speech Lang Pathol. 2021 Jun 18; 30 (3S):1361-1372 Epub 2021 Mar 09
    View PubMed
  14. Josephs KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Pham NTT, Stierwalt J, Ali F, Buciuc M, Baker M, Fernandez De Castro CH, Spychalla AJ, Schwarz CG, Reid RI, Senjem ML, Jack CR Jr, Lowe VJ, Bigio EH, Reichard RR, Polley EJ, Ertekin-Taner N, Rademakers R, DeTure MA, Ross OA, Dickson DW, Whitwell JL. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nat Commun. 2021 Jun 8; 12 (1):3452 Epub 2021 June 08
    View PubMed
  15. Mansukhani SA, Zalewski NL, Hur M, Ali F, Olsen TW, Bhatti MT, Chen JJ. Sea Fan Frond Neovascularization: A Unique Finding in a Patient With Susac Syndrome. J Neuroophthalmol. 2021 Jun 1; 41 (2):e160-e162
    View PubMed
  16. Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Front Neurol. 2021; 12:694872 Epub 2021 July 01
    View PubMed
  17. Jackson L, Klassen BT, Hassan A, Bower JH, Matsumoto JY, Coon EA, Ali F. Utility of tremor electrophysiology studies. Clin Park Relat Disord. 2021; 5:100108 Epub 2021 Sept 24
    View PubMed
  18. Sintini I, Kaufman K, Botha H, Martin PR, Loushin SR, Senjem ML, Reid RI, Schwarz CG, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL, Ali F. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy. Neuroimage Clin. 2021; 32:102850 Epub 2021 Oct 12
    View PubMed
  19. Seckin ZI, Duffy JR, Strand EA, Clark HM, Utianski RL, Machulda MM, Botha H, Ali F, Thu Pham NT, Lowe VJ, Whitwell JL, Josephs KA. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. Parkinsonism Relat Disord. 2020 Dec; 81:34-40. Epub 2020 Oct 07.
    View PubMed
  20. Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H, Duffy JR, Utianski RL, Buciuc M, Murray ME, Labuzan SA, Spychalla AJ, Pham NTT, Schwarz CG, Senjem ML, Machulda MM, Baker M, Rademakers R, Filippi M, Jack CR Jr, Lowe VJ, Parisi JE, Dickson DW, Josephs KA, Whitwell JL. Sensitivity-Specificity of Tau and Amyloid beta Positron Emission Tomography in Frontotemporal Lobar Degeneration. Ann Neurol. 2020 Nov; 88 (5):1009-1022 Epub 2020 Sept 12
    View PubMed
  21. Seckin ZI, Whitwell JL, Utianski RL, Botha H, Ali F, Duffy JR, Clark HM, Machulda MM, Jordan LG, Min HK, Lowe VJ, Josephs KA. Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech. J Neurol. 2020 Sep; 267 (9):2603-2611 Epub 2020 May 09
    View PubMed
  22. Clark HM, Stierwalt JAG, Tosakulwong N, Botha H, Ali F, Whitwell JL, Josephs KA. Dysphagia in Progressive Supranuclear Palsy. Dysphagia. 2020 Aug; 35 (4):667-676 Epub 2019 Nov 01
    View PubMed
  23. McCarter SJ, Stang C, Turcano P, Mielke MM, Ali F, Bower JH, Savica R. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia. Parkinsonism Relat Disord. 2020 Apr; 73:19-22 Epub 2020 Mar 16
    View PubMed
  24. Ali F, Wijdicks EF. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU. Neurocrit Care. 2020 Feb; 32 (1):286-294
    View PubMed
  25. Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin. 2020; 25:102152 Epub 2019 Dec 28
    View PubMed
  26. Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL. Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 Sep; 66:56-61. Epub 2019 Jul 02.
    View PubMed
  27. Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord. 2019 Aug; 34 (8):1144-1153 Epub 2019 Feb 06
    View PubMed
  28. Ali F, Kumar N, Dyck PJB, Berini S, Klaas J. Porphyria: A rare differential diagnosis of polyradiculoneuropathy. J Neurol Sci. 2019 Jul 15; 402:153-155 Epub 2019 May 22
    View PubMed
  29. Ali F, Botha H, Whitwell JL, Josephs KA. Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice. Mov Disord Clin Pract. 2019 Jul; 6 (6):436-439 Epub 2019 July 24
    View PubMed
  30. Whitwell JL, Stevens CA, Duffy JR, Clark HM, Machulda MM, Strand EA, Martin PR, Utianski RL, Botha H, Spychalla AJ, Senjem ML, Schwarz CG, Jack CR Jr, Ali F, Hassan A, Josephs KA. An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. Mov Disord Clin Pract. 2019 Jul; 6 (6):452-461 Epub 2019 May 29
    View PubMed
  31. Ali F, Josephs K. Rare Tauopathies. Semin Neurol. 2019 Apr; 39 (2):264-273 Epub 2019 Mar 29
    View PubMed
  32. Singh TD, Swanson A, Burrows AM, Clarke M, Shah S, Ali F, Coon EA. Teaching NeuroImages: Not a typical spinal mass. Neurology. 2018 Aug 21; 91 (8):e790-e791
    View PubMed
  33. Ali F, Josephs K. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother. 2018 Jul; 18 (7):603-616 Epub 2018 June 28
    View PubMed
  34. Ali F, Matsumoto JY, Hassan A. Camptocormia: Etiology, diagnosis, and treatment response. Neurol Clin Pract. 2018 Jun; 8 (3):240-248
    View PubMed
  35. Ali F, Whitwell JL, Martin PR, Senjem ML, Knopman DS, Jack CR, Lowe VJ, Petersen RC, Boeve BF, Josephs KA. [(18)F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation. J Neurol. 2018 May; 265 (5):1079-1088 Epub 2018 Mar 01
    View PubMed
  36. Ali F, Josephs KA. Corticobasal degeneration: key emerging issues. J Neurol. 2018 Feb; 265 (2):439-445 Epub 2017 Oct 23
    View PubMed
  37. Ali F, Murray JA, Adams AC, Flanagan EP. Clinical Reasoning: A 54-year-old woman with dementia, myoclonus, and ataxia. Neurology. 2017 Jul 11; 89 (2):e7-e12
    View PubMed
  38. Ali F, Laughlin RS. Asymptomatic CNS demyelination related to TNF-alpha inhibitor therapy. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4 (1):e298 Epub 2016 Oct 28
    View PubMed
  39. Ali F, Young J, Rabinstein AA, Flemming KD, Fugate JE. Routine Troponin Measurements Are Unnecessary to Exclude Asymptomatic Coronary Events in Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2016 May; 25 (5):1215-1221 Epub 2016 Feb 28
    View PubMed
  40. Siddiqui UT, Shakoor A, Kiani S, Ali F, Sharif M, Kumar A, Raza Q, Khan N, Alamzaib SM, Farid-ul-Husnain S. Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study. BMC Med Ethics. 2014 May 5; 15:36 Epub 2014 May 05
    View PubMed
  41. Abidi SH, Ali F, Shah F, Abbas F, Ali S. Burden of communicable disease among the native and repatriating Afghans. PLoS Pathog. 2012; 8 (10):e1002926 Epub 2012 Oct 25
    View PubMed
PST-20477991